Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azarga vs Cosopt in Open-Angle Glaucoma or Ocular Hypertension
NCT00314171Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of brinzolamide in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Mean Intraocular Pressure at 12 months. Started Oct 2005; status: completed.
02
Drugs
brinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00314171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314171.